313 related articles for article (PubMed ID: 32350915)
1. Cardiac troponin is associated with cardiac outcomes in men and women with atrial fibrillation, insights from the ARISTOTLE trial.
Røsjø H; Hijazi Z; Omland T; Westerbergh J; Lyngbakken MN; Alexander JH; Gersh BJ; Granger CB; Hylek EM; Lopes RD; Siegbahn A; Wallentin L
J Intern Med; 2020 Aug; 288(2):248-259. PubMed ID: 32350915
[TBL] [Abstract][Full Text] [Related]
2. Performance and Validation of a Novel Biomarker-Based Stroke Risk Score for Atrial Fibrillation.
Oldgren J; Hijazi Z; Lindbäck J; Alexander JH; Connolly SJ; Eikelboom JW; Ezekowitz MD; Granger CB; Hylek EM; Lopes RD; Siegbahn A; Yusuf S; Wallentin L;
Circulation; 2016 Nov; 134(22):1697-1707. PubMed ID: 27569438
[TBL] [Abstract][Full Text] [Related]
3. Comparison of cardiac troponins I and T measured with high-sensitivity methods for evaluation of prognosis in atrial fibrillation: an ARISTOTLE substudy.
Hijazi Z; Siegbahn A; Andersson U; Lindahl B; Granger CB; Alexander JH; Atar D; Gersh BJ; Hanna M; Harjola VP; Horowitz J; Husted S; Hylek EM; Lopes RD; McMurray JJ; Wallentin L
Clin Chem; 2015 Feb; 61(2):368-78. PubMed ID: 25451868
[TBL] [Abstract][Full Text] [Related]
4. N-terminal pro-B-type natriuretic peptide for risk assessment in patients with atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation).
Hijazi Z; Wallentin L; Siegbahn A; Andersson U; Christersson C; Ezekowitz J; Gersh BJ; Hanna M; Hohnloser S; Horowitz J; Huber K; Hylek EM; Lopes RD; McMurray JJ; Granger CB
J Am Coll Cardiol; 2013 Jun; 61(22):2274-84. PubMed ID: 23563134
[TBL] [Abstract][Full Text] [Related]
5. High-sensitivity troponin T and risk stratification in patients with atrial fibrillation during treatment with apixaban or warfarin.
Hijazi Z; Wallentin L; Siegbahn A; Andersson U; Alexander JH; Atar D; Gersh BJ; Hanna M; Harjola VP; Horowitz JD; Husted S; Hylek EM; Lopes RD; McMurray JJ; Granger CB;
J Am Coll Cardiol; 2014 Jan 7-14; 63(1):52-61. PubMed ID: 24055845
[TBL] [Abstract][Full Text] [Related]
6. Multi-biomarker risk stratification of N-terminal pro-B-type natriuretic peptide, high-sensitivity C-reactive protein, and cardiac troponin T and I in end-stage renal disease for all-cause death.
Apple FS; Murakami MM; Pearce LA; Herzog CA
Clin Chem; 2004 Dec; 50(12):2279-85. PubMed ID: 15364888
[TBL] [Abstract][Full Text] [Related]
7. Cardiac Biomarkers and Left Ventricular Hypertrophy in Relation to Outcomes in Patients With Atrial Fibrillation: Experiences From the RE - LY Trial.
Hijazi Z; Verdecchia P; Oldgren J; Andersson U; Reboldi G; Di Pasquale G; Mazzotta G; Angeli F; Eikelboom JW; Ezekowitz MD; Connolly SJ; Yusuf S; Wallentin L
J Am Heart Assoc; 2019 Jan; 8(2):e010107. PubMed ID: 30651032
[TBL] [Abstract][Full Text] [Related]
8. Sex-specific associations of established and emerging cardiac biomarkers with all-cause mortality in older adults: the ActiFE study.
Dallmeier D; Denkinger M; Peter R; Rapp K; Jaffe AS; Koenig W; Rothenbacher D;
Clin Chem; 2015 Feb; 61(2):389-99. PubMed ID: 25501933
[TBL] [Abstract][Full Text] [Related]
9. Repeated Measurements of Cardiac Biomarkers in Atrial Fibrillation and Validation of the ABC Stroke Score Over Time.
Hijazi Z; Lindahl B; Oldgren J; Andersson U; Lindbäck J; Granger CB; Alexander JH; Gersh BJ; Hanna M; Harjola VP; Hylek EM; Lopes RD; Siegbahn A; Wallentin L
J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28645934
[TBL] [Abstract][Full Text] [Related]
10. High-sensitivity troponin I for risk assessment in patients with atrial fibrillation: insights from the Apixaban for Reduction in Stroke and other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial.
Hijazi Z; Siegbahn A; Andersson U; Granger CB; Alexander JH; Atar D; Gersh BJ; Mohan P; Harjola VP; Horowitz J; Husted S; Hylek EM; Lopes RD; McMurray JJ; Wallentin L;
Circulation; 2014 Feb; 129(6):625-34. PubMed ID: 24226808
[TBL] [Abstract][Full Text] [Related]
11. Use of Biomarkers to Predict Specific Causes of Death in Patients With Atrial Fibrillation.
Sharma A; Hijazi Z; Andersson U; Al-Khatib SM; Lopes RD; Alexander JH; Held C; Hylek EM; Leonardi S; Hanna M; Ezekowitz JA; Siegbahn A; Granger CB; Wallentin L
Circulation; 2018 Oct; 138(16):1666-1676. PubMed ID: 29871978
[TBL] [Abstract][Full Text] [Related]
12. High-sensitivity cardiac troponin T and N-terminal pro-B-type natriuretic peptide in acute heart failure: Data from the ACE 2 study.
Berge K; Lyngbakken MN; Myhre PL; Brynildsen J; Røysland R; Strand H; Christensen G; Høiseth AD; Omland T; Røsjø H
Clin Biochem; 2021 Feb; 88():30-36. PubMed ID: 33245872
[TBL] [Abstract][Full Text] [Related]
13. Superiority of high sensitivity cardiac troponin T vs. I for long-term prognostic value in patients with chest pain; data from the Akershus cardiac Examination (ACE) 3 study.
Tveit SH; Myhre PL; Hoff NJS; Le TM; Seljeflot I; Røysland R; Høiseth AD; Røsjø H; Omland T
Clin Biochem; 2020 Apr; 78():10-17. PubMed ID: 31899280
[TBL] [Abstract][Full Text] [Related]
14. Sensitive troponin assays and N-terminal pro-B-type natriuretic peptide in acute coronary syndrome: prediction of significant coronary lesions and long-term prognosis.
Gravning J; Smedsrud MK; Omland T; Eek C; Skulstad H; Aaberge L; Bendz B; Kjekshus J; Mørkrid L; Edvardsen T
Am Heart J; 2013 May; 165(5):716-24. PubMed ID: 23622908
[TBL] [Abstract][Full Text] [Related]
15. Direct comparison of clinical decision limits for cardiac troponin T and I.
Kimenai DM; Henry RM; van der Kallen CJ; Dagnelie PC; Schram MT; Stehouwer CD; van Suijlen JD; Niens M; Bekers O; Sep SJ; Schaper NC; van Dieijen-Visser MP; Meex SJ
Heart; 2016 Apr; 102(8):610-6. PubMed ID: 26794233
[TBL] [Abstract][Full Text] [Related]
16. Prognostic role of highly sensitive cardiac troponin I in patients with systolic heart failure.
Tsutamoto T; Kawahara C; Nishiyama K; Yamaji M; Fujii M; Yamamoto T; Horie M
Am Heart J; 2010 Jan; 159(1):63-7. PubMed ID: 20102868
[TBL] [Abstract][Full Text] [Related]
17. Early release of high-sensitive cardiac troponin during complex catheter ablation for ventricular tachycardia and atrial fibrillation.
Reichlin T; Lockwood SJ; Conrad MJ; Nof E; Michaud GF; John RM; Epstein LM; Stevenson WG; Jarolim P
J Interv Card Electrophysiol; 2016 Oct; 47(1):69-74. PubMed ID: 26971332
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Value of Serial Changes in High-Sensitivity Cardiac Troponin I and T over 3 Months Using Reference Change Values in Hemodialysis Patients.
Sandoval Y; Herzog CA; Love SA; Cao J; Hu Y; Wu AH; Gilbertson D; Brunelli SM; Young A; Ler R; Apple FS
Clin Chem; 2016 Apr; 62(4):631-8. PubMed ID: 26847217
[TBL] [Abstract][Full Text] [Related]
19. Direct Comparison of Cardiac Troponin T and I Using a Uniform and a Sex-Specific Approach in the Detection of Functionally Relevant Coronary Artery Disease.
Mueller D; Puelacher C; Honegger U; Walter JE; Badertscher P; Schaerli N; Strebel I; Twerenbold R; Boeddinghaus J; Nestelberger T; Hollenstein C; du Fay de Lavallaz J; Jeger R; Kaiser C; Wild D; Rentsch K; Buser A; Zellweger M; Reichlin T; Mueller C
Clin Chem; 2018 Nov; 64(11):1596-1606. PubMed ID: 30097496
[TBL] [Abstract][Full Text] [Related]
20. High-sensitivity cardiac troponin T is superior to troponin I in the prediction of mortality in patients without acute coronary syndrome.
Árnadóttir Á; Vestergaard KR; Pallisgaard J; Sölétormos G; Steffensen R; Goetze JP; Iversen K
Int J Cardiol; 2018 May; 259():186-191. PubMed ID: 29477263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
